| abstract |
BACKGROUND OF THE INVENTION The present invention relates to orally administered trimebutin maleate film-coated tablets. The tablet is characterized by a heat core comprising 30-60% of trimebutin maleate and auxiliary agents for the stability and release of the active ingredient, and a transdermal film formulation, the effect of which is to temporarily, however, and premature release of the active ingredient. ŕ |